In this edition:

–  Apolipoprotein A1 infusions after acute MI
–  TAVI in patients with high-risk native aortic regurgitation
–  Combined use of GLP-1 agonists + SGLT2 inhibitors in patients with T2D
–  Cardiovascular effects of oral ketone ester treatment in patients with HFrEF
–  Impact of optimal vs poor statin adherence after STEMI
–  Transcatheter vs surgical treatment of aortic valve stenosis
–  Empagliflozin after acute MI
–  Use of artificial intelligence to predict AF
–  Aspirin vs clopidogrel for long-term maintenance after coronary stenting
–  Is excess apolipoprotein B associated with cardiovascular risk?

Download the Cardiology Research Review: Issue 165, with commentary by A/Prof John Amerena